Thomas P Lodise

55PUBLICATIONS
78CO-AUTHORS
Epidemiological modellingPharmacogenomicsDisease surveillanceEconomic models and forecastingMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (55)

|Sep 17, 2026
A US Hospital-Perspective Decision-Analytic Model of Once-Weekly Rezafungin Versus Daily Echinocandin Therapy in Hospitalized Adults With Candidemia or Invasive Candidiasis: Potential Cost Savings From Earlier Discharge.

|Sep 09, 2026
Comparative effectiveness of ceftolozane/tazobactam relative to ceftazidime/avibactam for the treatment of adult, hospitalized patients with pneumonia due to multidrug-resistant Pseudomonas aeruginosa in U.S. Veterans Health Administration facilities.

|Jun 12, 2026
Clinical Impact of the BIOFIRE® FILMARRAY® Pneumonia Panel in the Veterans Affairs Healthcare System: A Difference-in-Differences Study.

|Jun 11, 2026
Toward the Future: A Race-Agnostic, Bayesian Approach to Defining Glomerular Filtration for Personalized Drug Dosing.

|Sep 18, 2025
Comparison of early treatment with ceftolozane/tazobactam versus polymyxin-based therapy of pneumonia due to MDR Pseudomonas aeruginosa (PUMA).

Thomas P Lodise, Jae Min, Brian H Nathanson

|Sep 01, 2025
Association Between Duration of Candidemia and Clinical and Healthcare Resource Utilization Outcomes Among Hospitalized Adult Patients With Candidemia Who Received Empiric Treatment With an Echinocandin Across United States Hospitals.

Thomas P Lodise, Kevin W Garey, Jalal A Aram

Pageof 10

Frequent Collaborators

8 joint publications

J Nicholas O'Donnell

7 joint publications

Marc Scheetz

6 joint publications

Nimish Patel

4 joint publications

Michael J Rybak